CHINARES PHARMA (03320.HK): Pre-bid process starts on unit share issue

NewTimeSpace News: On 16 October 2026, China Resources Pharmaceutical Group Limited (stock code: 03320.HK) said its non-wholly-owned subsidiary China Resources Pharmaceutical Commercial Group Co., Ltd. (CR Pharmaceutical Commercial) proposes to issue new shares by public tender through an equity exchange under PRC rules on state-owned enterprise asset transactions (the Potential Issue). The number of new shares and the proceeds will be determined in due course.

The pre-bid process for the Potential Issue was launched through the China Beijing Equity Exchange (CBEX) on 16 October 2026, and CR Pharmaceutical Commercial published a pre-disclosure application for the capital increase on the CBEX site that day. The Potential Issue remains subject to a formal tender process by CBEX. The Board said CR Pharmaceutical Commercial has not entered any binding agreement for the Potential Issue and no assurance can be given that a transaction will proceed.